Related Experiment Videos
Primary cardiac sarcoma mimicking benign myxoma: a case report
Tasuku Hasegawa1, Susumu Nakagawa, Masao Chino
1Department of Cardiology, Tokyo Saiseikai Central Hospital, Mita 1-4-17, Minato-ku, Tokyo 108-0073.
Journal of Cardiology
|July 4, 2002
Summary
Primary cardiac sarcoma can mimic benign myxoma, leading to heart failure. Early detection through echocardiography is vital for distinguishing these malignant tumors from benign growths.
Area of Science:
- Cardiology
- Oncology
- Pathology
Background:
- Primary cardiac tumors are rare, with myxomas being the most common benign type.
- Malignant cardiac tumors, such as sarcomas, can present with symptoms mimicking benign conditions, delaying diagnosis and treatment.
- Accurate differentiation between benign and malignant cardiac masses is critical for patient outcomes.
Observation:
- A 53-year-old woman presented with progressive heart failure due to a primary cardiac sarcoma.
- Transesophageal echocardiography revealed multiple left atrial tumors resembling myxoma but with distinct origins and growth patterns.
- Surgical findings confirmed three separate tumors arising from different locations within the left atrium, histologically diagnosed as undifferentiated sarcoma.
Findings:
- The patient experienced rapid disease progression, with local recurrence and brain metastasis six months post-surgery.
- The clinical course, multiple tumor sites, and non-septal attachment were indicative of a malignant cardiac tumor.
- The patient's death occurred six months after surgery due to complications of the recurrent cardiac tumor and metastasis.
Implications:
- Echocardiography plays a crucial role in identifying features suggestive of malignant cardiac tumors, differentiating them from benign myxomas.
- Preoperative evaluation, including detailed echocardiographic assessment of tumor origin and multiplicity, is essential for accurate diagnosis.
- Prompt recognition and appropriate management of malignant cardiac tumors are vital for improving patient prognosis and survival rates.